TOIIW logo

Oncology Institute (TOIIW)

Profile

Full Name

The Oncology Institute, Inc.

Ticker Symbol

TOIIW

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

Indexes

Not included

Website

http://theoncologyinstitute.com

Employees

825

Key Details

Price

$0.07(+9.32%)

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$393.41M(+21.33% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.07
TOIIW price is $0.07

30-Day Relative Volume

0.18
TOIIW 30-day relative volume is 0.18

Price Performance

Price Most recent change

+9.32%
TOIIW price was up +9.32% on May 2, 2025

Price YTD change

+1207.69%
TOIIW price is up +1207.69% since January 1st

Price 1-year change

-60.47%
TOIIW price is down -60.47% year-on-year

Price 3-year change

-
TOIIW price 3-year change is unknown

Price Range

Price All-time high

$1.01
TOIIW price is currently -93.27% below its historical high of $1.01

Price 3-year low

$0.01
TOIIW price is currently +1207.69% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

-
TOIIW market capitalization value is unknown

Market cap 3-year change

-
TOIIW market capitalization 3-year change is unknown

Market cap All-time high

-
TOIIW market capitalization all-time high is unknown

Market cap sector rank

-
TOIIW market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

-
TOIIW shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
TOIIW shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.48
TOIIW beta is 2.48

200-day SMA

$0.03
TOIIW price is currently +107.95% above its 200-day simple moving average

50-day SMA

$0.04
TOIIW price is currently +81.33% above its 50-day simple moving average

RSI

54.07
TOIIW 14-day relative strength index is 54.07

Volume

0.18
TOIIW 30-day relative volume is 0.18

ATR

$0.02
TOIIW average true range is $0.02

10-day Historical Volatility

937.15%
TOIIW 10-day historical volatility is 937.15%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$393.41M
TOIIW annual revenue is $393.41 million

Revenue Analysts estimate

-
TOIIW annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+21.33%
TOIIW annual revenue is up +21.33% year-on-year

Revenue Sector rank

71.65%
TOIIW annual revenue is higher than 71.65% of companies in Healthcare sector

EPS

EPS

-
TOIIW annual earnings per share value is unknown

EPS Analysts estimate

-
TOIIW annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-
TOIIW annual earnings per share 1-year change is unknown

EPS Sector rank

-
TOIIW annual earnings per share is unknown

Profit

Gross profit

$54.00M
TOIIW annual gross profit is $54.00 million

Gross margin

13.73%
TOIIW annual gross profit margin is 13.73%

Operating profit

-$60.12M
TOIIW annual operating income is -$60.12 million

Operating margin

-15.28%
TOIIW annual operating profit margin is -15.28%

Net income

-$64.66M
TOIIW annual net profit is -$64.66 million

Net margin

-
TOIIW annual net profit margin value is unknown

Expenses

Total expenses

$453.53M
TOIIW annual total expenses is $453.53 million

Operating expenses

$114.11M
TOIIW annual total operating expenses is $114.11 million

Cost of goods sold

$339.42M
TOIIW annual cost of goods sold is $339.42 million

Selling, general & administrative expenses

$107.83M
TOIIW annual SGA is $107.83 million

Depreciation and amortization

$6.29M
TOIIW annual depreciation & amortization is $6.29 million

Interest expense

$7.50M
TOIIW annual interest expense is $7.50 million

Income tax

$0.00
TOIIW annual income tax is $0.00

EBIT & EBITDA

EBIT

-$57.17M
TOIIW annual earnings before interest & taxes is -$57.17 million

EBITDA

-$54.20M
TOIIW annual EBITDA is -$54.20 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$172.72M
TOIIW annual total assets is $172.72 million

Non current assets

$60.30M
TOIIW annual long term assets is $60.30 million

Current assets

$112.42M
TOIIW annual total current assets is $112.42 million

Cash and cash equivalents

$49.67M
TOIIW annual cash & cash equivalents is $49.67 million

Accounts receivable

$48.34M
TOIIW annual accounts receivable is $48.34 million

Inventory

$10.04M
TOIIW annual inventory is $10.04 million

Liabilities

Total liabilities

$169.13M
TOIIW annual total liabilities is $169.13 million

Long term liabilities

$116.91M
TOIIW annual total long term liabilities is $116.91 million

Current liabilities

$52.22M
TOIIW annual total current liabilities is $52.22 million

Accounts payable

$24.32M
TOIIW annual accounts payable is $24.32 million

Debt

Total debt

$123.15M
TOIIW annual total debt is $123.15 million

Total debt 1-year change

+2.91%
TOIIW annual total debt is up +2.91% year-on-year

Long term debt

$116.35M
TOIIW annual long term debt is $116.35 million

Short term debt

-
TOIIW annual short term debt value is unknown

Equity & Capital

Shareholders equity

$3.59M
TOIIW annual stockholders equity is $3.59 million

Book value

-$18.45M
TOIIW annual book value is -$18.45 million

Retained earnings

-$210.81M
TOIIW annual retained earnings is -$210.81 million

Working capital

$60.20M
TOIIW annual working capital is $60.20 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$26.54M
TOIIW annual cash flow from operations is -$26.54 million

Cash from operations 1-year change

+26.92%
TOIIW annual cash flow from operations is up +26.92% year-on-year

Cash from investing

$46.21M
TOIIW annual cash flow from investing activities is $46.21 million

Cash from investing 1-year change

-26.23%
TOIIW annual cash flow from investing activities is down -26.23% year-on-year

Cash from financing

-$3.49M
TOIIW annual cash flow from financing activities is -$3.49 million

Cash from financing 1-year change

+49%
TOIIW annual cash flow from financing activities is up +49% year-on-year

CAPEX

CAPEX

$3.79M
TOIIW annual capital expenditures is $3.79 million

CAPEX 1-year change

-17.04%
TOIIW annual capital expenditures is down -17.04% year-on-year

Free Cash Flow

Free cash flow

-$30.33M
TOIIW annual free cash flow is -$30.33 million

Free cash flow 1-year change

+25.82%
TOIIW annual free cash flow is up +25.82% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

13.73%
TOIIW annual gross profit margin is 13.73%

Operating margin

-15.28%
TOIIW annual operating profit margin is -15.28%

Net margin

-
TOIIW annual net profit margin value is unknown

ROA & ROE

ROA

-37.44%
TOIIW annual return on assets is -37.44%

ROE

-1801.70%
TOIIW annual return on equity is -1801.70%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TOIIW price to earnings ratio value is unknown

PE ratio Sector rank

-
TOIIW price to earnings ratio is unknown

PB Ratio

PB ratio

-
TOIIW price to book ratio value is unknown

PB ratio Sector rank

-
TOIIW price to book ratio is unknown

PS Ratio

PS ratio

-
TOIIW price to sales ratio value is unknown

PS ratio Sector rank

-
TOIIW price to sales ratio is unknown

Enterprise value

Enterprise value

-
TOIIW enterprise value value is unknown

Enterprise value Sector rank

-
TOIIW enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
TOIIW EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
TOIIW EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.15
TOIIW annual current ratio is 2.15

Quick ratio

1.96
TOIIW annual quick ratio is 1.96

Leverage

Debt to equity

34.31
TOIIW annual debt to equity ratio is 34.31

Interest coverage ratio

-7.63
TOIIW annual interest coverage ratio is -7.63

Risk & Stability

Piotroski F-Score

-
TOIIW piotroski f-score value is unknown

Altman Z-Score

-
TOIIW altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

  • What is the ticker symbol for Oncology Institute?
  • Does Oncology Institute pay dividends?
  • What sector is Oncology Institute in?
  • What industry is Oncology Institute in?
  • What country is Oncology Institute based in?
  • Is Oncology Institute in the S&P 500?
  • Is Oncology Institute in the NASDAQ 100?
  • Is Oncology Institute in the Dow Jones?
  • When does Oncology Institute report earnings?

What is the ticker symbol for Oncology Institute?

The ticker symbol for Oncology Institute is NASDAQ:TOIIW

Does Oncology Institute pay dividends?

No, Oncology Institute does not pay dividends

What sector is Oncology Institute in?

Oncology Institute is in the Healthcare sector

What industry is Oncology Institute in?

Oncology Institute is in the Medical Care Facilities industry

What country is Oncology Institute based in?

Oncology Institute is headquartered in United States

Is Oncology Institute in the S&P 500?

No, Oncology Institute is not included in the S&P 500 index

Is Oncology Institute in the NASDAQ 100?

No, Oncology Institute is not included in the NASDAQ 100 index

Is Oncology Institute in the Dow Jones?

No, Oncology Institute is not included in the Dow Jones index

When does Oncology Institute report earnings?

The date for Oncology Institute's next earnings report has not been announced yet
On this page